Literature DB >> 22458901

Renal cell carcinoma with clear cell and papillary features.

Hillary Ross1, Guido Martignoni, Pedram Argani.   

Abstract

CONTEXT: The diagnosis of primary renal cell carcinomas (RCCs) with both papillary architecture and cells with clear cytoplasm can be diagnostically challenging for practicing pathologists. The 4 main neoplasms in the differential diagnosis are clear cell RCC, papillary RCC, clear cell papillary RCC, and Xp11 translocation RCC. Accurate diagnosis has both prognostic and therapeutic implications.
OBJECTIVE: To highlight the helpful cytomorphologic, immunohistochemical, and cytogenetic features of each of these entities to enable reproducible classification. DATA SOURCES: Published peer-reviewed literature was reviewed, accompanied by the authors' personal experiences.
CONCLUSIONS: Key morphologic clues and a focused immunohistochemical panel, including CK7, α-methylacyl coenzyme A racemase (AMACR), TFE3, cathepsin K, and carbonic anhydrase IX (CAIX), now allow most resected RCCs with papillary architecture and clear cells to be accurately classified. In other cases, cytogenetic and molecular findings can establish the diagnosis. Despite these tools, some RCCs with papillary architecture and clear cells do not fit into any of the described entities and currently remain unclassified.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22458901     DOI: 10.5858/arpa.2011-0479-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  24 in total

1.  A TOP2A-derived cancer panel drives cancer progression in papillary renal cell carcinoma.

Authors:  Mushi Ye; Zhuobin He; Wei Dai; Zhuo Li; Xiaojun Chen; Jianjun Liu
Journal:  Oncol Lett       Date:  2018-07-19       Impact factor: 2.967

Review 2.  Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma.

Authors:  Alberto Diaz de Leon; Ali Pirasteh; Daniel N Costa; Payal Kapur; Hans Hammers; James Brugarolas; Ivan Pedrosa
Journal:  Radiographics       Date:  2019-06-14       Impact factor: 5.333

Review 3.  Clear cell papillary renal cell carcinoma: a review.

Authors:  Naoto Kuroda; Chisato Ohe; Fumi Kawakami; Shuji Mikami; Mitsuko Furuya; Keiko Matsuura; Masatsugu Moriyama; Yoji Nagashima; Ming Zhou; Fredrik Petersson; José I López; Ondrej Hes; Michal Michal; Mahul B Amin
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

4.  Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.

Authors:  Hanan AlSaeid Alshenawy
Journal:  Pathol Oncol Res       Date:  2015-02-25       Impact factor: 3.201

Review 5.  Recent classification of renal epithelial tumors.

Authors:  Naoto Kuroda; Azusa Tanaka
Journal:  Med Mol Morphol       Date:  2013-03-26       Impact factor: 2.309

6.  Tubulocystic carcinoma of the kidney: a histologic, immunohistochemical, and ultrastructural study.

Authors:  Borislav A Alexiev; Cinthia B Drachenberg
Journal:  Virchows Arch       Date:  2013-03-24       Impact factor: 4.064

7.  Xp11.2 translocation renal cell carcinoma with multiple bone metastases: A case report.

Authors:  Jiaju Liu; Zhengming Su; Yifan Li; Duqun Chen; Liangchao Ni; Xiangming Mao; Shangqi Yang; Yongqing Lai
Journal:  Oncol Lett       Date:  2016-02-09       Impact factor: 2.967

8.  Renal cell carcinoma in tuberous sclerosis complex.

Authors:  Ping Yang; Kristine M Cornejo; Peter M Sadow; Liang Cheng; Mingsheng Wang; Yu Xiao; Zhong Jiang; Esther Oliva; Sergiusz Jozwiak; Robert L Nussbaum; Adam S Feldman; Elahna Paul; Elizabeth A Thiele; Jane J Yu; Elizabeth P Henske; David J Kwiatkowski; Robert H Young; Chin-Lee Wu
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

Review 9.  Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors.

Authors:  Anna Caliò; Matteo Brunelli; Stefano Gobbo; Pedram Argani; Enrico Munari; George Netto; Guido Martignoni
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

10.  Combination of four gene markers to detect circulating tumor cells in the peripheral blood of patients with advanced lung adenocarcinoma using real-time PCR.

Authors:  Yan Yu; Gang Xu; Jingyan Cao; Shi Jin; Yingchun Man; Lihua Shang
Journal:  Oncol Lett       Date:  2013-02-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.